Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS
Condition:   Multidrug Resistant Tuberculosis Interventions:   Drug: Bedaquiline;   Drug: Pyrazinamide;   Drug: Linezolid;   Drug: Cycloserine;   Drug: Clofazimine Sponsor:   Huashan Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2021 Category: Research Source Type: clinical trials

Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB
Condition:   Tuberculosis Interventions:   Drug: Meropenem Injection;   Drug: Amoxicillin Clavulanate;   Drug: Pyrazinamide;   Drug: Bedaquiline;   Drug: Rifafour Sponsor:   TASK Applied Science Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials

A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
Condition:   Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Interventions:   Drug: Bedaquiline;   Drug: Clarithromycin;   Drug: Ethambutol;   Drug: Rifampicin;   Drug: Rifabutin Sponsor:   Janssen Pharmaceutical K.K. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials

Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB
Condition:   Tuberculosis Interventions:   Drug: Meropenem Injection;   Drug: Amoxicillin Clavulanate;   Drug: Pyrazinamide;   Drug: Bedaquiline;   Drug: Rifafour Sponsor:   TASK Applied Science Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials

A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
Condition:   Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Interventions:   Drug: Bedaquiline;   Drug: Clarithromycin;   Drug: Ethambutol;   Drug: Rifampicin;   Drug: Rifabutin Sponsor:   Janssen Pharmaceutical K.K. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials

Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB
Condition:   Tuberculosis Interventions:   Drug: Meropenem Injection;   Drug: Amoxicillin Clavulanate;   Drug: Pyrazinamide;   Drug: Bedaquiline;   Drug: Rifafour Sponsor:   TASK Applied Science Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials

A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
Condition:   Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Interventions:   Drug: Bedaquiline;   Drug: Clarithromycin;   Drug: Ethambutol;   Drug: Rifampicin;   Drug: Rifabutin Sponsor:   Janssen Pharmaceutical K.K. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials

Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB
Condition:   Tuberculosis Interventions:   Drug: Meropenem Injection;   Drug: Amoxicillin Clavulanate;   Drug: Pyrazinamide;   Drug: Bedaquiline;   Drug: Rifafour Sponsor:   TASK Applied Science Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials

A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
Condition:   Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Interventions:   Drug: Bedaquiline;   Drug: Clarithromycin;   Drug: Ethambutol;   Drug: Rifampicin;   Drug: Rifabutin Sponsor:   Janssen Pharmaceutical K.K. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials

Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB
Condition:   Tuberculosis Interventions:   Drug: Meropenem Injection;   Drug: Amoxicillin Clavulanate;   Drug: Pyrazinamide;   Drug: Bedaquiline;   Drug: Rifafour Sponsor:   TASK Applied Science Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials

A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
Condition:   Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Interventions:   Drug: Bedaquiline;   Drug: Clarithromycin;   Drug: Ethambutol;   Drug: Rifampicin;   Drug: Rifabutin Sponsor:   Janssen Pharmaceutical K.K. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials

Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB
Condition:   Tuberculosis Interventions:   Drug: Meropenem Injection;   Drug: Amoxicillin Clavulanate;   Drug: Pyrazinamide;   Drug: Bedaquiline;   Drug: Rifafour Sponsor:   TASK Applied Science Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials

A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
Condition:   Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Interventions:   Drug: Bedaquiline;   Drug: Clarithromycin;   Drug: Ethambutol;   Drug: Rifampicin;   Drug: Rifabutin Sponsor:   Janssen Pharmaceutical K.K. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials

Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB
Condition:   Tuberculosis Interventions:   Drug: Meropenem Injection;   Drug: Amoxicillin Clavulanate;   Drug: Pyrazinamide;   Drug: Bedaquiline;   Drug: Rifafour Sponsor:   TASK Applied Science Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials

A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
Condition:   Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) Interventions:   Drug: Bedaquiline;   Drug: Clarithromycin;   Drug: Ethambutol;   Drug: Rifampicin;   Drug: Rifabutin Sponsor:   Janssen Pharmaceutical K.K. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2020 Category: Research Source Type: clinical trials

Evaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081
Condition:   Pulmonary Tuberculosis Interventions:   Drug: WX-081;   Drug: Bedaquiline;   Drug: Standard treatment;   Drug: Multi-drug background treatment (MBT) Sponsor:   Shanghai Jiatan Pharmatech Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2020 Category: Research Source Type: clinical trials

PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE)
Conditions:   Infections and Infestations;   Pulmonary Tuberculosis Interventions:   Drug: Delpazolid;   Drug: Bedaquiline, Delamanid, Moxifloxacin Sponsors:   LegoChem Biosciences, Inc;   Ludwig-Maximilians - University of Munich;   Radboud University;   University of California, San Francisco Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2020 Category: Research Source Type: clinical trials

Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis
Condition:   Tuberculosis Intervention:   Drug: Total oral short-term therapy that includes linezolid, bedaquiline and/or cycloserine. Sponsor:   Beijing Chest Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2020 Category: Research Source Type: clinical trials